These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8303883)

  • 41. [Anti-env and anti-gag antibodies in subjects infected with the human immunodeficiency virus].
    Sanz del Forcallo FJ; García Delgado R; Ortiz Maslloréns F
    Rev Clin Esp; 1989 Dec; 185(9):443-7. PubMed ID: 2696006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of regions of HIV-1 p24 reactive with sera which give "indeterminate" results in electrophoretic immunoblots with the help of long synthetic peptides.
    Blomberg J; Vincic E; Jönsson C; Medstrand P; Pipkorn R
    AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1363-72. PubMed ID: 2127683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of antibodies to p24 and gp41 epitopes of HIV by ELISA using the recombinant core protein (p24) and envelope synthetic protein (gp41).
    Filice G; Soldini L; Orsolini P; Razzini E; Chiapparoli L; Gulminetti R; Cattaneo E; Achilli G
    Microbiologica; 1991 Jan; 14(1):1-7. PubMed ID: 1906127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
    Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM
    AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advances in methods for the production, purification, and characterization of HIV-1 Gag-Env pseudovirion vaccines.
    Hammonds J; Chen X; Zhang X; Lee F; Spearman P
    Vaccine; 2007 Nov; 25(47):8036-48. PubMed ID: 17936444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conformational changes between human immunodeficiency virus type 1 nucleocapsid protein NCp7 and its precursor NCp15 as detected by anti-NCp7 monoclonal antibodies.
    Tanchou V; Delaunay T; Bodéus M; Roques B; Darlix JL; Benarous R
    J Gen Virol; 1995 Oct; 76 ( Pt 10)():2457-66. PubMed ID: 7595349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Group- and type-specific antibodies to the gag-gene protein p26 of the human immunodeficiency virus immunological type 2 in infected patients].
    Kliushnik SIu; Selimova LM; Veselovskaia TV; Zaĭdes VM
    Biull Eksp Biol Med; 1991 Mar; 111(3):283-4. PubMed ID: 2054505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Random expression of human immunodeficiency virus-1 (HIV-1) p17 (epitopes) on the surface of the HIV-1-infected cell.
    Ota A; Liu X; Fujio H; Sakato N; Ueda S
    Hybridoma; 1998 Feb; 17(1):73-5. PubMed ID: 9523241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of the anti-HIV-1 activity of an anti-p17-derivative peptide (P30-52) monoclonal antibody.
    Ota A; Ueda S
    Hybridoma; 1999 Aug; 18(4):305-14. PubMed ID: 10571260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice.
    Chenciner N; Michel F; Dadaglio G; Langlade-Demoyen P; Hoffenbach A; Leroux A; Garcia-Pons F; Rautmann G; Guy B; Guillon JM
    Eur J Immunol; 1989 Sep; 19(9):1537-44. PubMed ID: 2676560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies.
    Abacioglu YH; Fouts TR; Laman JD; Claassen E; Pincus SH; Moore JP; Roby CA; Kamin-Lewis R; Lewis GK
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):371-81. PubMed ID: 8068416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccine.
    Akahata W; Yang ZY; Nabel GJ
    J Virol; 2005 Jan; 79(1):626-31. PubMed ID: 15596858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The immunoenzyme detection of the HIV-1 antigen by using monoclonal antibodies to protein p24].
    Shumaĭ EP; Vorob'ev SM; Makarova NE; Tugizov ShM; Zverev VV; Kushch AA
    Vopr Virusol; 1992; 37(5-6):229-32. PubMed ID: 1290220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The isolation and characteristics of recombinant monoclonal antibodies to the Lassa virus].
    Vladyko AS; Kunitskaia LIa; Bystrova SI; Kras'ko AG; Lemeshko NN; Lukashevich IS
    Vopr Virusol; 1990; 35(5):396-8. PubMed ID: 2267781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cleavage and purification of prokaryotically expressed HIV gag and env fusion proteins for detection of HIV antibodies in the ELISA.
    Ellinger S; Mach M; Korn K; Jahn G
    Virology; 1991 Feb; 180(2):811-3. PubMed ID: 1989391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chimeric HIV-1 virus-like particles containing gp120 epitopes as a result of a ribosomal frameshift elicit Gag- and SU-specific murine cytotoxic T-lymphocyte activities.
    Tobin GJ; Li GH; Fong SE; Nagashima K; Gonda MA
    Virology; 1997 Sep; 236(2):307-15. PubMed ID: 9325238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The antigenic and immunogenic properties of a recombinant protein of the HIV-1 gag-pol gene secreted by Saccharomyces cerevisiae yeast cells].
    Trushinskaia GN; Grudinin MP; Denisova GF; Gibadulin RA
    Vopr Virusol; 1992; 37(1):19-22. PubMed ID: 1413708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120.
    AIDS Vaccine Evaluation Group 022 Protocol Team
    J Infect Dis; 2001 Feb; 183(4):563-70. PubMed ID: 11170981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [IPO-10 monoclonal antibodies to the human B-lymphocyte differentiation antigen].
    Sidorenko SP; Vetrova EP; Berdova AG; Shlapatskaia LN; Evsev'eva AI
    Eksp Onkol; 1988; 10(3):42-4. PubMed ID: 2457482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.